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Abstract 24 
Proteolysis is a complex and dynamic process which takes place throughout the whole dry-25 
cured processing due to the action of endogenous muscle peptidases, and results in the 26 
generation of a high number of small peptides and free amino acids responsible for the final 27 
quality of dry-cured ham. In this study, a total of sixty-eight peptides derived from the 28 
ubiquitin-60S ribosomal protein have been identified in dry-cured ham at 2, 3.5, 5, 6.5, and 9 29 
months of processing using various chromatographic separations and a quadrupole/time-of-30 
flight mass spectrometer in tandem. Some of the identified peptides have been detected during 31 
the whole process, whereas a total of fourteen of them were exclusively identified at 9 months 32 
of curing. The presence of any of these peptides could be a good indicative that dry-cured 33 
ham pieces have reached a minimum curing process of 9 months. The study of the generated 34 
peptides has contributed both to a better knowledge of proteolysis evolution and the 35 
endogenous enzymes participating, and to determine their potential to be used as quality 36 
markers to control the processing time. 37 
 38 
 39 
 40 
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1. Introduction 44 
Protein degradation is a phenomena that occurs both in vivo, as one of the tactics employed by 45 
the cell for irreversible inactivating the proteins, and post-mortem, which has been widely 46 
reported during the last decades due to its importance in the final quality characteristics of 47 
meat and meat-derived products. There are two major pathways to control the destruction of 48 
intracellular proteins in vivo, the ubiquitin proteasome system (UPS), and the autophagy 49 
lysosome system (Wustrow, Zhou, & Rolfe, 2013). In the UPS, the proteins that are destined 50 
for degradation are targeted to the 26S proteasome by covalent attachment of a multi-51 
ubiquitin chain. As a result, an enzymatic cascade that includes two ubiquitin-activating 52 
enzymes (E1s), approximately forty ubiquitin conjugating enzymes (E2s), and more than five 53 
hundred ubiquitin ligases (E3s) occurs. In the final step of this cascade, is the ubiquitin ligase 54 
the enzyme that controls the specificity of the ubiquitination reaction. Different studies 55 
suggested that the UPS plays an important role in the degradation of muscle proteins under 56 
various catabolic conditions, and the degradation of ubiquitin in quadriceps femoris beef 57 
muscle, that almost disappear at 10 days post-mortem, has been previously reported 58 
(Sekikawa, Seno, & Mikami, 1998). 59 
The natural protein degradation occurred in the post-mortem period during the maturation or 60 
curing processes of meat has been widely reported during the last decade. In this respect, 61 
fragments of peptides and amino acids are generated in large amounts from the progressive 62 
enzymatic degradation of sarcoplasmic and myofibrillar proteins, contributing to flavour, 63 
texture, and final quality of meat-derived products such as dry-cured ham (Aristoy & Toldrá, 64 
1995; Toldrá & Flores, 1998; Lametsch, Karlsson, Rosenvold, Andersen, Roepstorff & 65 
Bendixen, 2003). 66 
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The processing of dry-cured ham is very long, lasting up to 24 months in the highest quality 67 
pieces, and its final economic value is mainly given according to the porcine breed and the 68 
time of curing. Analytical methods to control the time of curing and the final quality of dry-69 
cured ham would be very useful to assure that fraudulent or accidental mislabeling does not 70 
arise, especially when sold as sliced ham packages. The advances carried out during the last 71 
years in the techniques used in the separation of small peptides as well as the experimental 72 
design used in proteomic researches, have allowed an increase in the knowledge of the 73 
specific peptide sequences generated as well as its tracking during the whole curing process. 74 
This fact could permit the control of the dry-cured processing through the study of some of 75 
the identified peptide sequences as markers of the time of curing. Recently, a total of 107 76 
sequences of peptides naturally generated from the degradation of the LIM domain-binding 77 
protein 3 at different times of curing during the processing of dry-cured ham have been 78 
identified using an ion trap mass spectrometer (Gallego, Mora, Fraser, Aristoy, & Toldrá, 79 
2013) and its potential as markers of time of processing  discussed. 80 
In the present study, ubiquitin-60S ribosomal protein degradation has been studied at different 81 
times during the dry-cured ham processing (2, 3.5, 5, 6.5, and 9 months). The sequences of 82 
the identified peptides will allow to study its evolution through the process as well as to 83 
elucidate the possible proteolytic enzymes that are responsible for its generation. Finally, the 84 
potential of some of the identified peptides to be used as markers to control the processing 85 
time is discussed.2. Materials and methods 86 
2.1 Spanish dry-cured ham processing 87 
This study was done by triplicate using raw hams from 6 months old pig (Landrace x Large 88 
White) for the production of Spanish dry-cured ham according to the methodology described 89 
by Gallego et al. (2013). Briefly, hams were bled and prepared according to traditional 90 
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procedures consisting on the pre-salting stage for 30 min; the salting period where hams were 91 
entirely buried in salt and placed in a cold room for 10-12 days at 2-4 ºC and 90-95% relative 92 
humidity; the post-salting stage where hams were kept for 60 days at 4-5 ºC and 75-85% 93 
relative humidity; and the ripening-drying period at temperatures increasing from 5 ºC to 14-94 
20 ºC and relative humidity decreasing to 70%. The total length of the dry-curing process was 95 
9 months. Samples were taken at 2 months, 3.5 months, 5 months, 6.5 months, and 9 months 96 
of processing. 97 
2.2 Extraction of peptides and deproteinisation 98 
Fifty g samples of Biceps femoris muscle coming from each sampling time of the processed 99 
Spanish dry-cured hams were minced and homogenised with 200 mL of 0.01 N HCl for 8 100 
minutes in a stomacher (IUL Instrument, Barcelona, Spain). The homogenate was centrifuged 101 
at 4 ºC and 12000 g for 20 min. The resulting supernatant was filtered through glass wool and 102 
deproteinised by adding 3 volumes of ethanol maintaining the sample at 4 ºC for 20 hours. 103 
Finally, the sample was centrifuged again at 4 ºC and 12000 g for 10 min and the supernatant 104 
was dried in a rotatory evaporator. The dried deproteinised extract was dissolved in 25 mL of 105 
0.01 N HCl, filtered through a 0.45 µm nylon membrane filter (Millipore, Bedford, MA) and 106 
stored at -20 ºC until use. 107 
2.3 Size-exclusion chromatography 108 
Size-exclusion chromatography was used to fractionate deproteinised cured ham extracts 109 
according to molecular mass. A 5 mL aliquot of each extract filtered through a 0.45 µm nylon 110 
membrane filter (Millipore) was injected in a Sephadex G25 column (2.5 x 65 cm, Amersham 111 
Biosciencies, Uppsala, Sweden), previously equilibrated with 0.01 N HCl. The separation was 112 
performed using 0.01 N HCl as mobile phase, at a flow rate of 15 mL/h and 4 ºC, and 113 
fractions of 5 mL were collected using an automatic fraction collector and further monitored 114 
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by ultraviolet absorption at 214 nm (Ultrospec 3000 UV/Visible spectrophotometer, 115 
Pharmacia Biotech, Cambridge, England). Fractions corresponding to elution volumes from 116 
125 to 160 mL were pooled together and aliquots of 100 L were lyophilised for the mass 117 
spectrometry analysis. 118 
2.4 Peptide identification by mass spectrometry in tandem (nESI-LC-MS/MS) 119 
The nanoLC-MS/MS analysis was performed using an Eksigent Nano-LC Ultra 1D Plus 120 
system (Eksigent of AB Sciex, CA, USA) coupled to the quadrupole-time-of-flight (Q-ToF) 121 
TripleTOF® 5600+ system from AB Sciex Instruments (Framingham, MA, USA) that is 122 
equipped with a nanoelectrospray ionization source. 123 
Lyophilised samples were resuspended in 100 L of H2O with 0.1% of trifluoroacetic acid 124 
(TFA). Twenty microlitres of each sample at different times of processing were cleaned and 125 
concentrated using Zip-Tip C18 with standard bed format (Millipore Corporation, Bedford, 126 
MA) according to manufacturer’s instructions and kept at -20ºC until analysis. Five 127 
microlitres of the supernatant were injected into the LC-MS system through the autosampler. 128 
Samples were then preconcentrated on an Eksigent C18 trap column (3, 350m x 0.5mm) 129 
(Eksigent of AB Sciex, CA, USA), at a flow rate of 3 µL/min and using 0.1% v/v TFA as 130 
mobile phase. After 5 min of preconcentration, the trap column was automatically switched 131 
in-line onto a nano-HPLC capillary column (3µm, 75µm x 12.3 cm, C18) (Nikkyo Technos 132 
Co, Ltd. Japan). The mobile phases consisted of solvent A, containing 0.1% v/v FA in water, 133 
and solvent B, containing 0.1% v/v FA in 100% acetonitrile. Chromatographic conditions 134 
were a linear gradient from 5% to 35% of solvent B over 90 min, and 10 min from 35% to 135 
65% of solvent B, at a flow rate of 0.30 μL/min and running temperature of 30 ºC. 136 
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The outlet of the capillary column was directly coupled to a nano-electrospray ionisation 137 
system (nano-ESI). The Q/ToF was operated in positive polarity and information-dependent 138 
acquisition mode, in which a 0.25-s ToF MS scan from m/z of 300 to 1250 was performed, 139 
followed by 0.05-s product ion scans from m/z of 100 to 1500 on the 50 most intense 1 to 5 140 
charged ions.  141 
2.5 Data analysis 142 
Automated spectral processing, peak list generation, and database search were performed 143 
using Mascot Distiller v2.4.2.0 software (Matrix Science, Inc., Boston, MA) 144 
(hppt://www.matrixscience.com). The identification of protein origin of peptides was done 145 
using UniProt protein database, with a significance threshold p<0.05 and a FDR of 0.5. The 146 
tolerance on the mass measurement was 0.3 Da in MS mode and 0.3 Da for MS/MS ions. 147 
3. Results and discussion 148 
Sample extracts were deproteinised by precipitation with ethanol and fractionated by size-149 
exclusion chromatography. Those fractions corresponding to the first eluted peak (a total of 7 150 
fractions of 5 mL) were pooled together and lyophilised for nESI-LC-MS/MS mass 151 
spectrometry identification of their peptidic content.  152 
A total of sixty-eight peptides generated from ubiquitin-60S ribosomal protein have been 153 
identified at five different times of processing. The sequences of the identified peptides 154 
together with the m/z obtained in the detector as well as the molecular mass calculated 155 
according to the charge of ionisation are reported in Table 1. The time of processing when the 156 
peptides have been identified is also indicated in order to facilitate the tracking of the 157 
sequences. 158 
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Figure 1 shows the sequence of the ubiquitin-60S ribosomal protein, and peptides identified 159 
are indicated with black arrows. The identified peptides cover a 56% of the studied sequence 160 
with accession number P63053 according to UniProtKB/Swiss-Prot database. All of them 161 
have been identified between positions 3 and 74 of this sequence. Although the ubiquitin 162 
system of cellular protein degradation has been widely investigated in the fields of clinical 163 
medicine and cellular biology, there are not many studies about the state of this protein in 164 
post-mortem muscle (Sekikawa et al., 1998), and to our knowledge, no reports regarding 165 
naturally generated ubiquitin peptides have been previously published. 166 
Enzymes involved in the extense proteolysis occurred during the processing of dry-cured ham 167 
are muscle endopeptidases such as cathepsins and calpains, which hydrolyse proteins giving 168 
rise to large polypeptides; and exopeptidases like aminopeptidases, carboxypeptidases, 169 
peptidyl peptidases and peptidases, which degrade polypeptides to small peptides and free 170 
amino acids (Toldrá & Flores, 1998; Toldrá, Aristoy & Flores, 2000). Cathepsins are stable 171 
during the full process (Toldrá, Rico & Flores, 1993), although cathepsin D activity 172 
disappears after 6 months of processing (Toldrá et al., 1993). Calpains are inactivated after 173 
the salting stage (Rosell & Toldrá, 1996), and regarding exopeptidases, only the activity of 174 
aminopeptidases and dipeptidyl peptidases have been studied along the curing process, 175 
showing good stability during this period of time (Toldrá, Flores & Sanz, 1997; Toldrá et al., 176 
2000; Sentandreu & Toldrá, 2001). 177 
Evidences about the activity of exopeptidases in the generation of the peptides identified from 178 
position 3 to position 74 of the ubiquitin-60S ribosomal protein sequence are shown in Figure 179 
1, with the consecutive loss of amino acids, dipeptides, and tripeptides, from both terminal 180 
sites. These results are better appreciated in Table 1, where the sequences of the identified 181 
peptides have been aligned according to the sequence. In this sense, previous studies discuss 182 
the role of these exopeptidases in the generation of small peptides and amino acids at the end 183 
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of the dry-curing process in proteins such as actin (Sentandreu, Armenteros, Calvete, Ouali, 184 
Aristoy & Toldrá, 2007), myosin light chain and titin (Mora, Sentandreu, Koistinen, Fraser, 185 
Toldrá & Bramley, 2009), troponin T (Mora, Sentandreu & Toldrá, 2010), sarcoplasmic 186 
proteins like creatine kinase (Mora, Sentandreu, Fraser, Toldrá & Bramley, 2009), myoglobin 187 
(Mora & Toldrá, 2012) or glycolytic enzymes (Mora, Valero, Sánchez del Pino, Sentandreu & 188 
Toldrá, 2011). In this respect, the identification of the sequences of these small naturally 189 
generated peptides has become only possible through the use of advanced proteomic 190 
techniques such as tandem mass spectrometry like Time-of-Flight (ToF-ToF), ion trap (Q-191 
Trap), and Quadrupole/Time-of-Flight mass spectrometers. 192 
Table 1 shows the time of processing, in months, when the different peptide sequences have 193 
been detected. This information reveals the complexity, dynamism, and variability of 194 
proteolysis phenomena as a result of the random action of muscle peptidases, that result in the 195 
generation of a complex mixture of peptides with unspecified cleavage sites (Gallego et al., 196 
2013). The smallest peptides such as dipeptides or tripeptides that result from the degradation 197 
of ubiquitin protein are not able to be identified under the conditions specified in the MS 198 
analysis as it would be difficult to relate their sequence to a specific protein origin due to the 199 
high amount of possible matches when considering the whole pig proteome. This fact would 200 
explain the unidentification of the peptides MQ, MQI or MQIF from position 1-2, 1-3, and 1-201 
4 of ubiquitin sequence, respectively, although it would be expected to have them in the 202 
extract of dry-cured ham.  203 
A total of sixteen of the identified peptides remain stable during the 9 months of the studied 204 
processing period (Table 1). However, other peptides remain intact only during the first 5 205 
months of processing and disappear at 6.5 and 9 months (peptides 17 and 18), whereas 206 
fourteen of the peptides (from peptide 52 to peptide 65) appear only at 9 months of 207 
processing. As an example, Figure 2 shows the MS/MS spectra of peptides 52 and 53, where 208 
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it is shown the loss of the dipeptide KA due to the action of exopeptidases in the C-terminal 209 
site. Moreover, these peptides could be a good indicative for a minimum curing time of 9 210 
months. This fact suggests the potential of some of the identified peptides, derived from the 211 
natural degradation of ubiquitin protein, to be used as biomarkers in this type of product with 212 
the aim to give a good estimation and control of the time of processing.  213 
4. Conclusions 214 
An increase in the knowledge of the specific peptide sequences generated from muscle 215 
proteolysis has been achieved during the last years. This situation has been possible through 216 
the use of modern advances carried out in separation techniques for small peptides, and 217 
proteomic experimental design, which have been used to identify natural peptides generated 218 
during the curing process. This fact could permit the control of the dry-cured processing 219 
through the study of some of the identified peptide sequences as markers of the time of 220 
curing. In fact, a better control of the processing chain of dry-cured ham would guarantee its 221 
safety and quality, making them more suitable for export trade, betting for the consumer 222 
protection. The ubiquitin peptides identified in this study provide an evidence of the action of 223 
aminopeptidases, carboxypeptidases, and di- and tripeptidyl peptidases to the release of 224 
peptides and free amino acids during the processing of dry-cured ham, and some of the 225 
identified sequences have resulted to be detected only at 9 months of processing, which 226 
indicates the potential of the peptides generated during the dry-curing to be used as markers 227 
of the time of processing. 228 
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FIGURE CAPTIONS 279 
Figure 1. Primary sequence of ubiquitin 60S ribosomal protein from Sus scrofa 280 
(UniprotKB/Swiss-Prot protein database accession number P63053). Cleavage sites of the 281 
identified peptides at each time of processing are indicated with black arrows. 282 
Figure 2.   MS/MS spectra of ions 616.29
2+
 and 387.72
2+
 that correspond to peptides 52 and 283 
53, respectively, detected at 9 months of dry-cured ham processing. 284 
 285 
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Figure 1. Mora et al. 
Figure 1
Table 1- Peptides identified by nESI-LC-MS/MS derived from ubiquitin 60S ribosomal protein at different times of dry-cured ham processing. 
 
Obtained Charge Calculated
Pept. (m/z )
a
 (+) (Mr )
b
P0 Sequence Pf 2 3.5 5 6.5 9
3' IFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLR 74'
1 423.77 2 845.52 T      LTGKTITL E
2 587.87 2 1173.73 F   VKTLTGKTITL E
3 900.46 2 1798.93 L              EVEPSDTIENVKAKIQ D
4 957.98 2 1913.96 L              EVEPSDTIENVKAKIQD K
5 511.52 4 2042.05 L              EVEPSDTIENVKAKIQDK E
6 680.33 2 1358.66 L              EVEPSDTIENVK A
7 715.85 2 1429.69 L              EVEPSDTIENVKA K
8 487.59 3 1459.75 P                  SDTIENVKAKIQD K
9 491.77 4 1963.09 V                         KAKIQDKEGIPPDQQRL I
10 612.67 3 1834.99 K                          AKIQDKEGIPPDQQRL I
11 514.28 3 1539.84 D                               KEGIPPDQQRLIF A
12 576.80 2 1151.59 K                                EGIPPDQQRL I
13 640.85 2 1279.69 D                               KEGIPPDQQRL I
14 698.36 2 1394.72 Q                              DKEGIPPDQQRL I
15 649.31 2 1296.62 L                                                       SDYNIQKESTL H
16 548.29 2 1094.56 D                                                         YNIQKESTL H
17 483.27 3 1446.78 L                                          IFAGKQLEDGRTL S
18 604.97 3 1811.91 L                                          IFAGKQLEDGRTLSDY N
19 636.13 5 3175.64 L              EVEPSDTIENVKAKIQDKEGIPPDQQRL I
20 661.40 2 1320.80 I  FVKTLTGKTITL E
21 726.41 3 2176.20 E                       NVKAKIQDKEGIPPDQQRL I
22 367.27 2 732.44 K     TLTGKTI T
23 531.33 2 1060.65 F   VKTLTGKTIT L
24 661.45 2 1320.80 Q IFVKTLTGKTIT L
25 719.78 2 1437.78 V                         KAKIQDKEGIPPD Q
26 404.25 5 2016.06 G                                                    RTLSDYNIQKESTLHLV L
27 321.24 3 960.55 L       TGKTITLEV E
28 495.19 2 988.54 T        GKTITLEVE P
29 588.99 3 1763.95 A                           KIQDKEGIPPDQQRL I
30 587.74 2 1173.69 Q                                        RLIFAGKQLE D
Time of processing (months)c
Table 1
(Table 1 continued) 
 
31 767.91 2 1533.82 L                                          IFAGKQLEDGRTLS D
32 659.83 2 1317.65 A                                             GKQLEDGRTLSD Y
33 449.24 3 1344.70 D                                                         YNIQKESTLHL V
34 616.82 2 1231.62 D                                                         YNIQKESTLH L
35 302.87 3 905.59 L                                                                  HLVLRLR G
36 375.75 2 749.49 L                                                                  HLVLRL R
37 397.71 2 793.40 D                                                         YNIQKE S
38 779.90 2 1557.79 L             EVEPSDTIENVKAK I
39 512.28 2 1022.55 E                                 GIPPDQQRL I
40 483.77 2 965.53 G                                  IPPDQQRL I
41 449.25 3 1344.72 P                 SDTIENVKAKIQ D
42 381.89 3 1142.67 D                   TIENVKAKIQ D
43 629.85 2 1257.69 D                   TIENVKAKIQD K
44 474.29 2 946.57 K     LTGKTITL E
45 736.87 2 1471.74 T            LEVEPSDTIENVK A
46 528.23 2 1054.46 L                                                EDGRTLSDY N
47 550.62 3 1648.84 L                                          IFAGKQLEDGRTLSD Y
48 466.75 2 931.50 Y                                                         NIQKESTL H
49 348.21 3 1041.62 T                    IENVKAKIQ D
50 462.93 3 1385.79 D                   TIENVKAKIQDK E
51 367.22 2 732.44 L      TGKTITL E
52 616.29 2 1230.56 L             EVEPSDTIENV K
53 387.72 2 773.43 D                   TIENVKA K
54 420.24 3 1257.69 S                  DTIENVKAKIQ D
55 427.23 2 852.45 I                                   PPDQQRL I
56 613.85 2 1225.68 G                                  IPPDQQRLIF A
57 642.35 2 1282.70 E                                 GIPPDQQRLIF A
58 552.63 3 1654.87 Q                              DKEGIPPDQQRLIF A
59 1020.00 2 2038.08 K                                EGIPPDQQRLIFAGKQLE D
60 706.88 2 1411.75 K                                EGIPPDQQRLIF A
61 584.31 2 1166.60 D                               KEGIPPDQQR L
62 879.95 2 1757.95 D                                      QQRLIFAGKQLEDGR T
(Table 1 continued) 
 
 
 
 
 
 
 
 
63 518.27 3 1551.75 F                                            AGKQLEDGRTLSDY N
64 555.27 2 1108.54 T                                                      LSDYNIQKE S
65 377.69 2 753.37 G                                                    RTLSDY N
66 406.20 2 810.39 D                                                   GRTLSDY N
67 414.23 2 826.45 Q                                                             KESTLHL V
68 441.22 2 880.43 D                                                         YNIQKES T
a. Molecular ion mass observed in the nESI-LC-MS/MS analysis; b. Calculated molecular mass in Da of the matched peptide; c. Peptides identified at each time of curing.
 1 
Peptide 52: EVEPSDTIENV (616.29, 2+) 
 
 
Peptide 53: TIENVKA (387.72, 2+) 
 
 2 
 3 
Figure 2. Mora et al. 4 
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Table 2
Highlights 
 
Novel peptides extracted, purified and identified in Spanish dry-cured ham 
Ham peptides analysed through advanced proteomics tools 
Natural generated peptides as potential biomarkers of dry-cured ham processing   
Highlights (for review)
